Conceptual macro photograph of amber particles moving through a cyan glass microfluidic pathway

Absorption, decoded

DHM bioavailability: the ingredient is only the beginning.

Follow the path from dose to measurable exposure—and learn why formulation, route, and study model change what the evidence can actually say.

Conceptual editorial visualNot a clinical result
01Ingredient
02Formulation
03Exposure
04Evidence

The short answer

Having DHM in a capsule is not the same as knowing how much reaches circulation—or what that exposure means for a person.

The molecule-to-moment runway

Four gates stand between an ingredient and a result.

Bioavailability is one piece of the chain. Each gate asks a different question, and skipping one makes the headline less useful.

01
Enter · Dose + form

What reaches the system?

The ingredient source, dose, format, and surrounding formula define the starting point.

02
Release · Dissolution

What becomes available?

A compound has to leave its dosage form and enter solution before absorption is even possible.

03
Cross · Absorption

What crosses the barrier?

Preclinical studies suggest raw DHM has solubility and exposure challenges. Route and model matter.

04
Measure · Exposure

What can researchers detect?

Concentration over time can describe exposure. It does not, by itself, prove a consumer outcome.

Read the curve, not the hype

Exposure is a shape—not a slogan.

Researchers often look at concentration over time. The height, timing, and area of that curve can change with formulation and route.

Illustrative exposure trace Measurement window
Measured concentration
Time →
Illustrative only. Not Joyrise clinical data.
Formulation
patent
US11871770B1

Keep the nouns straight

A patent describes the invention. Evidence evaluates the outcome.

Joyrise has a patented formulation approach. That is meaningful product context—but it is not a guarantee, a human trial, or proof that every person will feel the same result.

Explore the evidence room

The current Joyrise bottle

Know exactly what you’re buying.

Current label facts, clear serving math, a patented formulation, and limits that stay visible.

45capsules
15labeled servings
3capsules per serving
$1.99per labeled serving

$29.99 one-time bottle

Shop Joyrise capsules 30-day money-back guarantee · terms apply

Five straight answers

Before the label becomes a promise.

What does bioavailability mean?+

Bioavailability describes the proportion and rate at which a compound reaches systemic circulation. The exact meaning depends on the compound, route, formulation, and study design.

Is raw DHM highly bioavailable?+

Preclinical literature describes solubility, absorption, and rapid-clearance challenges for DHM. That research is useful context, but it is not the same as a human outcome study of every finished product.

Does a formulation patent prove that Joyrise works?+

No. A patent describes an invention. It does not prove a guaranteed consumer outcome. Finished-product evidence, study design, and endpoints must be considered separately.

How many servings are in the Joyrise bottle?+

The current bottle contains 45 capsules, 15 labeled servings, and 3 capsules per labeled serving. At $29.99, that is $1.99 per labeled serving.

Does Joyrise lower BAC or impairment?+

No. Joyrise does not lower BAC, reverse impairment, or make driving safe. Only time lowers BAC.

The better question

Not “How much DHM?”
“What happens next?”

Start with the label, follow the pathway, inspect the evidence, then choose the ritual that fits your plan.

Shop Joyrise Joyrise does not reduce BAC or impairment and does not make drinking safer. Never drink and drive.

A little more ready for your plans

Your cart 0